News on Medial

Related News

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven

EntrackrEntrackr · 1m ago
Healthians posts Rs 263 Cr revenue in FY25; nears breakeven
Medial

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven Healthians didn't manage notable growth in the fiscal year ending March 2025. However, the WestBridge-backed company narrowed its losses by 89% year on year and neared break-even during the same period. The firm’s operating revenue increased 8% year-on-year to Rs 263 crore in FY25, up from Rs 243 crore in FY24, as per its consolidated financial statements filed with the Registrar of Companies (RoC). Including non-operating income of Rs 7 crore, the company’s total income grew 7% to Rs 270 crore during the year. Cost optimisation played a key role in supporting the company’s financial recovery. Total expenses declined 8% to Rs 275 crore in FY25, compared to Rs 298 crore last year. Among the major cost heads, employee benefits, the largest expense category, dropped 13% year-on-year to Rs 104 crore in FY25 from Rs 120 crore in FY24. Cost of materials contracted 7% to Rs 54 crore. Advertising costs rose 10% to Rs 43 crore. Meanwhile, depreciation and finance costs remained stable at Rs 29 crore and Rs 15 crore, respectively. The improvement in revenue and control of key expenses helped Healthians bring down its losses sharply by 89% to Rs 5 crore in FY25 from Rs 45 crore in FY24. The firm posted positive EBITDA of Rs 32 crore in FY25 with EBITDA margin of 12.17%. Its ROCE stood at 2.73% in the same period. On a unit basis, the company spent Rs 1.05 to earn a rupee of operating revenue in FY25. The firm’s current assets increased slightly to Rs 170 crore including cash and bank balances worth Rs 49 crore in the fiscal. According to startup data intelligence platform TheKredible, Healthians has raised a total of $75 million of funding till date, having WestBridge, BEENEXT, DG Ventures and Youwecan as its lead investors. The company’s founder and CEO, Deepak Sahni owns 6.5% of the company.

2am VC launches Fund II to invest in 30 Indian startups

EntrackrEntrackr · 9m ago
2am VC launches Fund II to invest in 30 Indian startups
Medial

2am VC launches Fund II to invest in 30 Indian startups 2am VC, an early-stage India-only venture capital firm, has announced the formal launch of 2am VC Fund II. The fund will invest in innovative areas generated by the New India opportunity, including startups in consumer tech, fintech, food & beverage, AI, and global SaaS. According to 2am VC, Fund II plans to invest in up to 30 Indian startups, predominantly at the pre-seed to seed stage, aspiring to lead investment rounds and take meaningful ownership in companies to provide operational value to founders. 60% of the fund will be committed to initial investments, leaving 40% to support founders in follow-on investments. 2am VC connects global investors with Indian founders as a hyperlocal partner, curating deal flow for global investors into the next generation of Indian founders while unlocking global resources for Indian founders to reach international networks and opportunities. The firm is dedicated to speed, transparency, founder-friendliness, and cross-border synergies, blending operational agility and institutional processes to effectively secure deals and go above and beyond to support founders. 2am VC states that it examines the key elements driving the New India, as founders build companies to tap into uniquely Indian contexts to better serve Indian end-users. The maturation of foundational models is giving way to new niche categories that meet emerging needs. The firm goes the extra mile to support founders as their hyperlocal and hyperglobal partners by introducing key relationships, arranging customers, and offering targeted guidance to support growth and achieve product-market fit. 2am VC has closed a $10 million Fund I. To date, 2am VC has invested in 47 companies, including notable startups such as NEWME, Apna Mart, Bimaplan, and Karbon Card, among others. Launched in 2021 by Hershel Mehta and Brendan Rogers, 2am VC is an early-stage Indian venture capital firm investing in innovative startups. With offices in Mumbai, Bengaluru, Delhi NCR, and Los Angeles, 2am VC blends the best of both East and West through the firm’s India Beachhead Strategy.

Healthians achieves EBITDA breakeven with Rs 250 Cr income in FY24

EntrackrEntrackr · 1y ago
Healthians achieves EBITDA breakeven with Rs 250 Cr income in FY24
Medial

Diagnostic startup Healthians recorded a modest 8% year-on-year growth during the fiscal year ending March 2024. However, the WestBridge-backed company reduced its losses by 65% and achieved EBITDA breakeven in the same period. Healthians’s revenue from operations increased to Rs 243 crore in FY24 from Rs 224 crore in FY23, its consolidated annual results sourced from the Ministry of Corporate Affairs (MCA) show. Healthians offers at-home diagnostic services across over 250 cities and claims to have conducted more than 10 crore tests to date. Income from running laboratories for pathological tests was the primary source of revenue for Healthians which increased 8.62% to Rs 240.5 crore in FY24. The rest of the collections were from the sale of supplements, which stood at Rs 2.2 crore in the last fiscal year. Healthians also added Rs 10 crore from non-operational activities (interest income) which tallied the overall revenue to Rs 253 crore in FY24, as compared to Rs 236 crore in FY23. The Gurugram-based company allocated 40% of its overall burn to employee benefits. This cost dropped by 11.8% to Rs 120 crore in FY24 compared to Rs 136 crore in FY23. Advertising expenses also shrank over 62% to Rs 39 crore in FY24 from Rs 103 crore in FY23. The cost of material consumed, rent, Information technology, and other overheads took the overall expenditure to Rs 298 crore in FY24. The controlled spending on advertising and employee benefits helped Healthians to narrow losses by 65% to Rs 45 crore in FY24. With this, the company has achieved EBITDA breakeven in the previous fiscal (FY24). Coming to the ratios, Healthians’ ROCE and EBITDA margins improved to -20.4% and 0% (breakeven) in FY24. It spent Rs 1.23 to earn a rupee in FY24. The company has a total current assets of Rs 62 crore including the cash and bank balances of Rs 30 crore in the previous fiscal. Healthians has raised around $80 million to date including its last round of $54 million led by WestBridge in 2022. According to the startup data intelligence platform TheKredible, WestBridge is the largest external stakeholder with 25% followed by Beenext and DG Ventures. Financial stability is the primary thing that a company needs to survive. It seems like Healthians got some of the mantras to how to be constant with the scale while burning low. Achieving EBITDA breakeven for the first time will give more confidence to both founders and investors. Turning this achievement into net profits is difficult yet achievable- an approach Dr. PathLabs has been executing for many years. The next two to three years will be crucial in shaping the company's trajectory.

Download the medial app to read full posts, comements and news.